nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A3—Irinotecan—colon cancer	0.288	0.406	CbGbCtD
Dopamine—SLC22A3—Vincristine—colon cancer	0.252	0.354	CbGbCtD
Dopamine—CYP2C9—Capecitabine—colon cancer	0.0756	0.107	CbGbCtD
Dopamine—CYP1A2—Fluorouracil—colon cancer	0.0498	0.0701	CbGbCtD
Dopamine—CYP2C9—Fluorouracil—colon cancer	0.0448	0.0632	CbGbCtD
Dopamine—Piloerection—Irinotecan—colon cancer	0.0172	0.186	CcSEcCtD
Dopamine—HTR7—myenteric nerve plexus—colon cancer	0.0169	0.138	CbGeAlD
Dopamine—Prolonged menses—Vincristine—colon cancer	0.0146	0.158	CcSEcCtD
Dopamine—HTR7—vein—colon cancer	0.0109	0.0887	CbGeAlD
Dopamine—Azotaemia—Vincristine—colon cancer	0.00575	0.062	CcSEcCtD
Dopamine—Menorrhagia—Vincristine—colon cancer	0.00414	0.0447	CcSEcCtD
Dopamine—HTR7—endothelium—colon cancer	0.00375	0.0305	CbGeAlD
Dopamine—Necrosis—Fluorouracil—colon cancer	0.00364	0.0393	CcSEcCtD
Dopamine—Extravasation—Vincristine—colon cancer	0.00351	0.0379	CcSEcCtD
Dopamine—DBH—digestive system—colon cancer	0.00349	0.0284	CbGeAlD
Dopamine—HTR7—blood vessel—colon cancer	0.00346	0.0281	CbGeAlD
Dopamine—Extravasation—Irinotecan—colon cancer	0.00342	0.0369	CcSEcCtD
Dopamine—Extravasation—Fluorouracil—colon cancer	0.00327	0.0353	CcSEcCtD
Dopamine—DBH—bone marrow—colon cancer	0.00322	0.0262	CbGeAlD
Dopamine—SLC22A2—renal system—colon cancer	0.0028	0.0228	CbGeAlD
Dopamine—Azotaemia—Methotrexate—colon cancer	0.00279	0.0301	CcSEcCtD
Dopamine—DRD5—lymphoid tissue—colon cancer	0.00272	0.0221	CbGeAlD
Dopamine—Mesalazine—PPARG—colon cancer	0.0027	0.703	CrCbGaD
Dopamine—DBH—liver—colon cancer	0.0026	0.0212	CbGeAlD
Dopamine—SLC22A3—embryo—colon cancer	0.0025	0.0203	CbGeAlD
Dopamine—Extrasystoles—Capecitabine—colon cancer	0.00237	0.0256	CcSEcCtD
Dopamine—COMT—smooth muscle tissue—colon cancer	0.00234	0.019	CbGeAlD
Dopamine—MAOB—embryo—colon cancer	0.00231	0.0188	CbGeAlD
Dopamine—SLC22A2—digestive system—colon cancer	0.0023	0.0187	CbGeAlD
Dopamine—COMT—renal system—colon cancer	0.00225	0.0183	CbGeAlD
Dopamine—Cyanosis—Methotrexate—colon cancer	0.0021	0.0227	CcSEcCtD
Dopamine—DBH—lymph node—colon cancer	0.00199	0.0162	CbGeAlD
Dopamine—SLC22A1—renal system—colon cancer	0.00198	0.0161	CbGeAlD
Dopamine—MAOA—embryo—colon cancer	0.00197	0.016	CbGeAlD
Dopamine—SLC22A3—smooth muscle tissue—colon cancer	0.00196	0.016	CbGeAlD
Dopamine—Necrosis—Methotrexate—colon cancer	0.00189	0.0204	CcSEcCtD
Dopamine—SLC22A3—renal system—colon cancer	0.00189	0.0154	CbGeAlD
Dopamine—COMT—digestive system—colon cancer	0.00184	0.015	CbGeAlD
Dopamine—Angina pectoris—Irinotecan—colon cancer	0.00182	0.0197	CcSEcCtD
Dopamine—MAOB—renal system—colon cancer	0.00175	0.0142	CbGeAlD
Dopamine—Angina pectoris—Fluorouracil—colon cancer	0.00175	0.0188	CcSEcCtD
Dopamine—Extravasation—Methotrexate—colon cancer	0.0017	0.0184	CcSEcCtD
Dopamine—COMT—bone marrow—colon cancer	0.0017	0.0138	CbGeAlD
Dopamine—HTR7—epithelium—colon cancer	0.00168	0.0137	CbGeAlD
Dopamine—HTR1A—renal system—colon cancer	0.00163	0.0133	CbGeAlD
Dopamine—COMT—vagina—colon cancer	0.00163	0.0133	CbGeAlD
Dopamine—HTR7—smooth muscle tissue—colon cancer	0.00162	0.0132	CbGeAlD
Dopamine—HTR7—renal system—colon cancer	0.00156	0.0127	CbGeAlD
Dopamine—Atrial fibrillation—Capecitabine—colon cancer	0.00153	0.0165	CcSEcCtD
Dopamine—Bradycardia—Irinotecan—colon cancer	0.00153	0.0165	CcSEcCtD
Dopamine—SLC6A4—digestive system—colon cancer	0.00151	0.0123	CbGeAlD
Dopamine—MAOA—renal system—colon cancer	0.00149	0.0121	CbGeAlD
Dopamine—MAOB—digestive system—colon cancer	0.00144	0.0117	CbGeAlD
Dopamine—SLC22A1—vagina—colon cancer	0.00143	0.0117	CbGeAlD
Dopamine—SLC22A5—renal system—colon cancer	0.00137	0.0112	CbGeAlD
Dopamine—COMT—liver—colon cancer	0.00137	0.0112	CbGeAlD
Dopamine—SLC22A3—vagina—colon cancer	0.00137	0.0111	CbGeAlD
Dopamine—HTR7—digestive system—colon cancer	0.00128	0.0104	CbGeAlD
Dopamine—MAOB—vagina—colon cancer	0.00127	0.0103	CbGeAlD
Dopamine—CYP2C19—digestive system—colon cancer	0.00125	0.0102	CbGeAlD
Dopamine—CYP1A2—renal system—colon cancer	0.00125	0.0101	CbGeAlD
Dopamine—MAOA—digestive system—colon cancer	0.00122	0.00996	CbGeAlD
Dopamine—Angina pectoris—Capecitabine—colon cancer	0.00122	0.0132	CcSEcCtD
Dopamine—SLC22A1—liver—colon cancer	0.00121	0.00984	CbGeAlD
Dopamine—Hypertension—Vincristine—colon cancer	0.00116	0.0125	CcSEcCtD
Dopamine—SLC22A3—liver—colon cancer	0.00116	0.0094	CbGeAlD
Dopamine—Mesalazine—PTGS2—colon cancer	0.00114	0.297	CrCbGaD
Dopamine—SLC22A5—digestive system—colon cancer	0.00113	0.00918	CbGeAlD
Dopamine—Hypertension—Irinotecan—colon cancer	0.00113	0.0121	CcSEcCtD
Dopamine—CYP2C19—vagina—colon cancer	0.0011	0.00899	CbGeAlD
Dopamine—MAOA—vagina—colon cancer	0.00108	0.0088	CbGeAlD
Dopamine—MAOB—liver—colon cancer	0.00107	0.0087	CbGeAlD
Dopamine—COMT—lymph node—colon cancer	0.00105	0.00857	CbGeAlD
Dopamine—CYP1A2—digestive system—colon cancer	0.00102	0.00831	CbGeAlD
Dopamine—Bradycardia—Capecitabine—colon cancer	0.00102	0.011	CcSEcCtD
Dopamine—SLC22A5—vagina—colon cancer	0.000996	0.0081	CbGeAlD
Dopamine—Tachycardia—Fluorouracil—colon cancer	0.000995	0.0107	CcSEcCtD
Dopamine—CYP2C9—digestive system—colon cancer	0.00097	0.00789	CbGeAlD
Dopamine—HTR7—liver—colon cancer	0.000954	0.00776	CbGeAlD
Dopamine—Dyspnoea—Irinotecan—colon cancer	0.000949	0.0102	CcSEcCtD
Dopamine—CYP2C19—liver—colon cancer	0.000932	0.00758	CbGeAlD
Dopamine—MAOA—liver—colon cancer	0.000912	0.00742	CbGeAlD
Dopamine—Dyspnoea—Fluorouracil—colon cancer	0.000909	0.00981	CcSEcCtD
Dopamine—CYP2D6—renal system—colon cancer	0.000887	0.00722	CbGeAlD
Dopamine—SLC22A3—lymph node—colon cancer	0.000886	0.00721	CbGeAlD
Dopamine—SLC22A5—liver—colon cancer	0.00084	0.00684	CbGeAlD
Dopamine—MAOB—lymph node—colon cancer	0.00082	0.00667	CbGeAlD
Dopamine—Palpitations—Capecitabine—colon cancer	0.000771	0.00832	CcSEcCtD
Dopamine—CYP1A2—liver—colon cancer	0.000761	0.00619	CbGeAlD
Dopamine—SLC6A2—lymph node—colon cancer	0.000759	0.00618	CbGeAlD
Dopamine—Hypertension—Capecitabine—colon cancer	0.000754	0.00813	CcSEcCtD
Dopamine—Anxiety—Capecitabine—colon cancer	0.000741	0.00799	CcSEcCtD
Dopamine—CYP2D6—digestive system—colon cancer	0.000728	0.00592	CbGeAlD
Dopamine—CYP2C9—liver—colon cancer	0.000722	0.00588	CbGeAlD
Dopamine—MAOA—lymph node—colon cancer	0.000699	0.00569	CbGeAlD
Dopamine—Tachycardia—Capecitabine—colon cancer	0.000695	0.0075	CcSEcCtD
Dopamine—Vomiting—Vincristine—colon cancer	0.000695	0.0075	CcSEcCtD
Dopamine—Headache—Vincristine—colon cancer	0.000685	0.00739	CcSEcCtD
Dopamine—Vomiting—Irinotecan—colon cancer	0.000677	0.0073	CcSEcCtD
Dopamine—Headache—Irinotecan—colon cancer	0.000667	0.00719	CcSEcCtD
Dopamine—Nausea—Vincristine—colon cancer	0.000649	0.007	CcSEcCtD
Dopamine—Vomiting—Fluorouracil—colon cancer	0.000648	0.00699	CcSEcCtD
Dopamine—SLC22A5—lymph node—colon cancer	0.000644	0.00524	CbGeAlD
Dopamine—Headache—Fluorouracil—colon cancer	0.000639	0.00689	CcSEcCtD
Dopamine—Dyspnoea—Capecitabine—colon cancer	0.000635	0.00685	CcSEcCtD
Dopamine—Nausea—Irinotecan—colon cancer	0.000632	0.00682	CcSEcCtD
Dopamine—Nausea—Fluorouracil—colon cancer	0.000606	0.00653	CcSEcCtD
Dopamine—CYP2D6—liver—colon cancer	0.000542	0.00441	CbGeAlD
Dopamine—Dyspnoea—Methotrexate—colon cancer	0.000473	0.0051	CcSEcCtD
Dopamine—Vomiting—Capecitabine—colon cancer	0.000453	0.00489	CcSEcCtD
Dopamine—Headache—Capecitabine—colon cancer	0.000446	0.00481	CcSEcCtD
Dopamine—Nausea—Capecitabine—colon cancer	0.000423	0.00457	CcSEcCtD
Dopamine—Vomiting—Methotrexate—colon cancer	0.000337	0.00364	CcSEcCtD
Dopamine—Headache—Methotrexate—colon cancer	0.000332	0.00358	CcSEcCtD
Dopamine—Nausea—Methotrexate—colon cancer	0.000315	0.0034	CcSEcCtD
Dopamine—DRD4—Signaling by GPCR—EGFR—colon cancer	1.82e-05	0.000256	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—PIK3CA—colon cancer	1.81e-05	0.000255	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—APC—colon cancer	1.79e-05	0.000253	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—NRAS—colon cancer	1.79e-05	0.000253	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CDKN1A—colon cancer	1.79e-05	0.000253	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—KRAS—colon cancer	1.79e-05	0.000252	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PPARG—colon cancer	1.77e-05	0.00025	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—APC—colon cancer	1.77e-05	0.000249	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—NRAS—colon cancer	1.77e-05	0.000249	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FGFR3—colon cancer	1.76e-05	0.000248	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.75e-05	0.000247	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—AKT1—colon cancer	1.74e-05	0.000246	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—PIK3CA—colon cancer	1.74e-05	0.000245	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.74e-05	0.000244	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—KRAS—colon cancer	1.72e-05	0.000242	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EP300—colon cancer	1.71e-05	0.00024	CbGpPWpGaD
Dopamine—COMT—Metabolism—PIK3CA—colon cancer	1.71e-05	0.00024	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—BRAF—colon cancer	1.69e-05	0.000238	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGFR3—colon cancer	1.68e-05	0.000237	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—BRAF—colon cancer	1.66e-05	0.000234	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SRC—colon cancer	1.66e-05	0.000234	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PPARG—colon cancer	1.65e-05	0.000233	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PTGS2—colon cancer	1.65e-05	0.000232	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—PIK3CA—colon cancer	1.65e-05	0.000232	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—EGFR—colon cancer	1.64e-05	0.00023	CbGpPWpGaD
Dopamine—MAOB—Metabolism—PIK3CA—colon cancer	1.62e-05	0.000228	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—colon cancer	1.62e-05	0.000228	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—APC—colon cancer	1.61e-05	0.000227	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—NRAS—colon cancer	1.61e-05	0.000227	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—EGFR—colon cancer	1.61e-05	0.000227	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.6e-05	0.000225	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NRAS—colon cancer	1.6e-05	0.000225	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—PIK3CA—colon cancer	1.58e-05	0.000222	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—PIK3CA—colon cancer	1.56e-05	0.00022	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—KRAS—colon cancer	1.54e-05	0.000218	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—APC—colon cancer	1.54e-05	0.000217	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—NRAS—colon cancer	1.54e-05	0.000217	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—PIK3CA—colon cancer	1.54e-05	0.000217	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—KRAS—colon cancer	1.52e-05	0.000215	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—HRAS—colon cancer	1.52e-05	0.000215	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—BRAF—colon cancer	1.52e-05	0.000214	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MYC—colon cancer	1.49e-05	0.000209	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—colon cancer	1.48e-05	0.000209	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—colon cancer	1.48e-05	0.000209	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGFR3—colon cancer	1.48e-05	0.000208	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—colon cancer	1.47e-05	0.000207	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—colon cancer	1.47e-05	0.000207	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HRAS—colon cancer	1.46e-05	0.000205	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.46e-05	0.000205	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—colon cancer	1.45e-05	0.000205	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—BRAF—colon cancer	1.45e-05	0.000204	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCND1—colon cancer	1.43e-05	0.000201	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ABCB1—colon cancer	1.43e-05	0.000201	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PIK3CA—colon cancer	1.42e-05	0.0002	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—colon cancer	1.42e-05	0.0002	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CTNNB1—colon cancer	1.41e-05	0.000199	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—colon cancer	1.41e-05	0.000198	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—colon cancer	1.41e-05	0.000198	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PIK3CA—colon cancer	1.41e-05	0.000198	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TYMS—colon cancer	1.4e-05	0.000197	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PIK3CA—colon cancer	1.4e-05	0.000197	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—colon cancer	1.39e-05	0.000196	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—colon cancer	1.39e-05	0.000196	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—KRAS—colon cancer	1.39e-05	0.000196	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDKN1A—colon cancer	1.38e-05	0.000195	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KRAS—colon cancer	1.37e-05	0.000193	CbGpPWpGaD
Dopamine—MAOA—Metabolism—EP300—colon cancer	1.37e-05	0.000193	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCND1—colon cancer	1.37e-05	0.000193	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PIK3CA—colon cancer	1.37e-05	0.000193	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.37e-05	0.000192	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APC—colon cancer	1.36e-05	0.000191	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—NRAS—colon cancer	1.36e-05	0.000191	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CTNNB1—colon cancer	1.35e-05	0.000191	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—colon cancer	1.35e-05	0.00019	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PIK3CA—colon cancer	1.34e-05	0.000189	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.33e-05	0.000187	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—KRAS—colon cancer	1.33e-05	0.000187	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN1A—colon cancer	1.32e-05	0.000186	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—colon cancer	1.32e-05	0.000186	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EP300—colon cancer	1.32e-05	0.000185	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HRAS—colon cancer	1.31e-05	0.000185	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ABCB1—colon cancer	1.31e-05	0.000185	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ABCB1—colon cancer	1.3e-05	0.000183	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—colon cancer	1.3e-05	0.000183	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—colon cancer	1.3e-05	0.000182	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TYMS—colon cancer	1.29e-05	0.000181	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—colon cancer	1.29e-05	0.000181	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SRC—colon cancer	1.28e-05	0.00018	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TYMS—colon cancer	1.28e-05	0.00018	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—colon cancer	1.28e-05	0.00018	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—colon cancer	1.28e-05	0.00018	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BRAF—colon cancer	1.27e-05	0.000179	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—colon cancer	1.26e-05	0.000178	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—colon cancer	1.26e-05	0.000178	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—colon cancer	1.26e-05	0.000177	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EP300—colon cancer	1.26e-05	0.000177	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—colon cancer	1.25e-05	0.000176	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—colon cancer	1.25e-05	0.000175	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—colon cancer	1.23e-05	0.000174	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—colon cancer	1.23e-05	0.000173	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRAS—colon cancer	1.23e-05	0.000173	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SRC—colon cancer	1.22e-05	0.000172	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—colon cancer	1.22e-05	0.000172	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—colon cancer	1.22e-05	0.000172	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—colon cancer	1.22e-05	0.000172	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—colon cancer	1.21e-05	0.000171	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—colon cancer	1.2e-05	0.000169	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—colon cancer	1.19e-05	0.000168	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—colon cancer	1.19e-05	0.000168	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—colon cancer	1.18e-05	0.000166	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—colon cancer	1.18e-05	0.000166	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRAS—colon cancer	1.18e-05	0.000166	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—colon cancer	1.18e-05	0.000166	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—colon cancer	1.17e-05	0.000164	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—colon cancer	1.17e-05	0.000164	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—EP300—colon cancer	1.16e-05	0.000163	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—colon cancer	1.16e-05	0.000163	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—colon cancer	1.15e-05	0.000162	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—colon cancer	1.15e-05	0.000161	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—colon cancer	1.14e-05	0.000161	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—colon cancer	1.14e-05	0.000161	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—colon cancer	1.14e-05	0.00016	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.14e-05	0.00016	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EP300—colon cancer	1.13e-05	0.00016	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—colon cancer	1.13e-05	0.000159	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—colon cancer	1.12e-05	0.000158	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EP300—colon cancer	1.12e-05	0.000158	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—colon cancer	1.12e-05	0.000157	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—colon cancer	1.11e-05	0.000156	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—colon cancer	1.11e-05	0.000156	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SRC—colon cancer	1.1e-05	0.000155	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—colon cancer	1.1e-05	0.000155	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—colon cancer	1.1e-05	0.000155	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—colon cancer	1.1e-05	0.000154	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—colon cancer	1.09e-05	0.000154	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TYMS—colon cancer	1.09e-05	0.000154	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—colon cancer	1.09e-05	0.000153	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SRC—colon cancer	1.09e-05	0.000153	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—EP300—colon cancer	1.08e-05	0.000152	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.08e-05	0.000152	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—colon cancer	1.07e-05	0.000151	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—colon cancer	1.07e-05	0.000151	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—colon cancer	1.07e-05	0.000151	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—colon cancer	1.07e-05	0.000151	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRAS—colon cancer	1.06e-05	0.000149	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—colon cancer	1.06e-05	0.000149	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—colon cancer	1.06e-05	0.000149	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—colon cancer	1.06e-05	0.000149	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—colon cancer	1.05e-05	0.000148	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRAS—colon cancer	1.05e-05	0.000147	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—colon cancer	1.04e-05	0.000147	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—colon cancer	1.03e-05	0.000145	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—colon cancer	1.02e-05	0.000144	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EP300—colon cancer	1.02e-05	0.000144	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—colon cancer	1.01e-05	0.000143	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—colon cancer	1.01e-05	0.000143	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—colon cancer	9.97e-06	0.00014	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—colon cancer	9.92e-06	0.00014	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—colon cancer	9.91e-06	0.00014	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SRC—colon cancer	9.91e-06	0.00014	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—colon cancer	9.88e-06	0.000139	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—colon cancer	9.85e-06	0.000139	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.83e-06	0.000138	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EP300—colon cancer	9.75e-06	0.000137	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—colon cancer	9.74e-06	0.000137	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—colon cancer	9.73e-06	0.000137	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—colon cancer	9.72e-06	0.000137	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—colon cancer	9.66e-06	0.000136	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—colon cancer	9.65e-06	0.000136	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—colon cancer	9.64e-06	0.000136	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—colon cancer	9.55e-06	0.000135	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRAS—colon cancer	9.53e-06	0.000134	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—colon cancer	9.53e-06	0.000134	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SRC—colon cancer	9.48e-06	0.000133	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—colon cancer	9.41e-06	0.000133	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—colon cancer	9.31e-06	0.000131	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—colon cancer	9.3e-06	0.000131	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—colon cancer	9.23e-06	0.00013	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—colon cancer	9.21e-06	0.00013	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—colon cancer	9.13e-06	0.000129	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—colon cancer	9.12e-06	0.000129	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRAS—colon cancer	9.12e-06	0.000128	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—colon cancer	9.05e-06	0.000127	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—colon cancer	9.01e-06	0.000127	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—colon cancer	9e-06	0.000127	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—colon cancer	9e-06	0.000127	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—colon cancer	8.99e-06	0.000127	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—colon cancer	8.88e-06	0.000125	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—colon cancer	8.86e-06	0.000125	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—colon cancer	8.75e-06	0.000123	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—colon cancer	8.68e-06	0.000122	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—colon cancer	8.62e-06	0.000121	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—colon cancer	8.58e-06	0.000121	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EP300—colon cancer	8.56e-06	0.000121	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—colon cancer	8.49e-06	0.00012	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—colon cancer	8.47e-06	0.000119	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.4e-06	0.000118	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—colon cancer	8.38e-06	0.000118	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SRC—colon cancer	8.32e-06	0.000117	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—colon cancer	8.31e-06	0.000117	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—colon cancer	8.29e-06	0.000117	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—colon cancer	8.27e-06	0.000117	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—colon cancer	8.2e-06	0.000116	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—colon cancer	8.11e-06	0.000114	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—colon cancer	8.1e-06	0.000114	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRAS—colon cancer	8.01e-06	0.000113	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—colon cancer	8e-06	0.000113	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—colon cancer	8e-06	0.000113	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—colon cancer	7.95e-06	0.000112	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—colon cancer	7.85e-06	0.000111	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—colon cancer	7.8e-06	0.00011	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—colon cancer	7.76e-06	0.000109	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—colon cancer	7.73e-06	0.000109	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—colon cancer	7.65e-06	0.000108	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—colon cancer	7.61e-06	0.000107	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—colon cancer	7.54e-06	0.000106	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—colon cancer	7.46e-06	0.000105	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—colon cancer	7.44e-06	0.000105	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—colon cancer	7.29e-06	0.000103	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—colon cancer	7.29e-06	0.000103	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—colon cancer	7.21e-06	0.000102	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—colon cancer	7.18e-06	0.000101	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—colon cancer	7.12e-06	0.0001	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—colon cancer	7.01e-06	9.87e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—colon cancer	6.97e-06	9.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—colon cancer	6.97e-06	9.82e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—colon cancer	6.89e-06	9.7e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—colon cancer	6.85e-06	9.65e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—colon cancer	6.76e-06	9.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—colon cancer	6.67e-06	9.4e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—colon cancer	6.53e-06	9.2e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—EP300—colon cancer	6.49e-06	9.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—colon cancer	6.33e-06	8.92e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—colon cancer	6.16e-06	8.67e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—colon cancer	6.12e-06	8.63e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—colon cancer	6.08e-06	8.56e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—EP300—colon cancer	5.97e-06	8.41e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—EP300—colon cancer	5.92e-06	8.34e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—colon cancer	5.89e-06	8.3e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—colon cancer	5.86e-06	8.25e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—colon cancer	5.17e-06	7.28e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—EP300—colon cancer	5.06e-06	7.12e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—colon cancer	4.8e-06	6.76e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—colon cancer	4.42e-06	6.22e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—colon cancer	4.38e-06	6.17e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—colon cancer	3.92e-06	5.52e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—colon cancer	3.74e-06	5.27e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—colon cancer	3.61e-06	5.08e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—colon cancer	3.58e-06	5.04e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—colon cancer	3.06e-06	4.3e-05	CbGpPWpGaD
